PROTEIN INTERACTION CORE
蛋白质相互作用核心
基本信息
- 批准号:8188884
- 负责人:
- 金额:$ 20.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-07-01 至
- 项目状态:未结题
- 来源:
- 关键词:ATP-Binding Cassette TransportersAdenovirus VectorAdenovirusesAffinityAffinity ChromatographyAllelesAlzheimer&aposs DiseaseAntibodiesAreaAutistic DisorderBaculovirus Expression SystemBase SequenceBehavior DisordersBindingBiochemicalBiochemical GeneticsBiological AssayBiological ProcessBrainC-terminalCMV promoterCaenorhabditis elegansCalciumCalmodulinCatalogingCatalogsCell LineCell NucleusCell physiologyCellsCentral Nervous System DiseasesCerebellar AtaxiaChimeric ProteinsCloningCollaborationsComplementComplementary DNAComplexComputer softwareConsultationsCore FacilityDNA Sequencing FacilityDatabasesDementiaDetectionDevelopmentDiseaseElectroporationElementsEpitopesFluorescence Resonance Energy TransferFluorochromeFusion Protein ExpressionGalactosidaseGene DeliveryGene ExpressionGene Expression RegulationGene TransferGenerationsGenesGeneticGenomicsGlioblastomaGoalsHousingHumanHuman ResourcesImageImmune responseIn VitroIndividualInstitutionInstructionIntegral Membrane ProteinInterphase CellLaboratoriesLaboratory PersonnelLeadLentivirus VectorLibrariesLifeLiposomesLuciferasesMaintenanceMapsMarketingMass Spectrum AnalysisMediatingMetabolic DiseasesMethodologyMethodsMicroscopyMigration AssayModificationNational Institute of Neurological Disorders and StrokeNerve DegenerationNervous system structureNeurodegenerative DisordersNeuronsNeurosciencesNormal CellOnline SystemsOpen Reading FramesOrganismParkinson DiseasePathway interactionsPhysiologicalPlasmidsPost-Translational Protein ProcessingPrecipitationPreparationProductionPromegaProtein FragmentProteinsProtocols documentationPublishingPuromycinRNA InterferenceReagentResearchResearch PersonnelResistanceResource SharingResourcesRetroviridaeRoleScreening procedureSecondary toServicesSignal TransductionSiteStreptavidinStudentsSubfamily lentivirinaeSystemSystems AnalysisTEV proteaseTechnologyTetanus Helper PeptideTetracycline ControlTetracyclinesTherapeutic AgentsTransfectionTwo-Hybrid System TechniquesUbiquitinUpdateVacciniaVacciniumVariantVenusViralViral GenesVirusYeastsadeno-associated viral vectorbasebiological systemsbody systemcDNA Librarycellular imagingcognitive functioncryogenicsdesigndesign and constructiondisease phenotypeenhanced green fluorescent proteinexperienceexperimental analysisexpression cloningexpression vectorgenetic linkage analysishigh throughput screeningin vivointerestnervous system disordernetwork modelsprogramspromoterprotein expressionprotein functionprotein protein interactionprotein purificationprotein structurereceptor couplingreconstitutionresearch studysensorsmall hairpin RNAsuccesstranscription factorvectorweb siteyeast two hybrid system
项目摘要
DESCRIPTION: In a post-genomic era, systems analyses have revealed interconnected networks between gene products. Such networks predict the relationship between interacting proteins and group proteins into clusters to facilitate definition of protein function. Understanding networks of protein-protein interactions in the brain will undoubtedly lead to a better understanding of neurological diseases and identify new targets for therapeutic agents.
Several large scale projects have used high throughput yeast two hybrid (Y2H) analyses to identify interacting products of open reading frames (ORES) of an organism. Functionally important protein interaction networks were defined and, for C elegans, it was shown that essential proteins often interact with one another ^^¿^^.
Similar analyses are useful for discovering common mechanisms of disorders of CNS development as illustrated by a recent study that examined a protein interaction network of cerebellar ataxias by Y2H and networking analyses ^^. The power of the Y2H approach in elucidating pathogenic mechanisms of neurodegenerative disorders is remarkable.
Many human neurodegenerative, developmental, and cognitive function disorders have been associated with multiple alleles. Multiple genes or genetic loci have also been implicated in complex disorders such as autism ^¿. Linkage analysis suggests that many genetic loci are associated with autism and it is conceivable that the
genes associated with autism could interconnect, having effects on similar cellular pathways (13-14,19). In addition, studies of diseases associated with a single gene have also benefited from studies of protein interactions. It is estimated that -80% of disease-associated SNPs destabilize a protein's structure and thereby may alter
interactions with other proteins (2,38,41). Efforts to understand how protein interactions mediate complex biological processes are maior components of the research goals of NINDS supported investigators at UAB.
Core C will facilitate progress in these areas.
We propose to maintain a Protein Interaction Core that offers expression of proteins in both prokaryotic and eukaryotic expression systems suitable for protein purification in-vitro and expression in-vivo, vector design and selection for in-vitro and in-vivo expression, biochemical and imaging characterization of protein
interactions including FRET and split luciferase/GFP, yeast two-hybrid screening systems and generation of constructs for tandem affinity purification (TAP) and mass spectroscopy. The goal of the Core Laboratory is to accelerate identification and characterization of biologically important protein interactions without the need to
establish these methodologies in individual NINDS supported laboratories. The Core Laboratory personnel will assist investigators in selection of appropriate screening systems, generate expression vector constructs for screening assays, and provide troubleshooting and technical assistance in the screening procedures. The
Core Laboratory will also facilitate the exchange of reagents and more importantly, expand an information and reagent sharing resource (www.neurosciencecore.uab.edu/coreclinks.htm ) that will permit individual
laboratories to share relevant experience with protein expression systems and interacting protein screening systems with other NINDS supported investigators at UAB. Finally, the core laboratory will limit redundancy in development of these methodologies and permit more efficient use of the resources provided by NINDS to investigate protein function in complex biologic systems that are the focus of study by NINDS supported investigators at UAB. Table 1 provides several examples of the interaction of the Protein Interaction Core Core C) with NINDS supported UAB investigators.
在后基因组时代,系统分析揭示了基因产物之间的相互连接网络。这种网络预测相互作用的蛋白质之间的关系,并将蛋白质分组为簇,以促进蛋白质功能的定义。了解大脑中蛋白质-蛋白质相互作用的网络无疑将有助于更好地了解神经系统疾病,并确定治疗药物的新靶点。
几个大规模项目已经使用高通量酵母双杂交(Y2 H)分析来鉴定生物体的开放阅读框(ORES)的相互作用产物。功能上重要的蛋白质相互作用网络被定义,并且对于秀丽隐杆线虫,它表明必需的蛋白质经常相互作用^^。
类似的分析对于发现中枢神经系统发育障碍的共同机制是有用的,最近的一项研究通过Y2 H和网络分析来检查小脑共济失调的蛋白质相互作用网络^^。Y2 H方法在阐明神经退行性疾病的致病机制方面的能力是显著的。
许多人类神经退行性、发育和认知功能障碍与多个等位基因相关。多个基因或遗传位点也与自闭症等复杂疾病有关。连锁分析表明,许多基因位点与自闭症有关,可以想象,
与自闭症相关的基因可以相互连接,对相似的细胞通路产生影响(13- 14,19)。此外,与单个基因相关的疾病研究也受益于蛋白质相互作用的研究。据估计,约80%的疾病相关SNP使蛋白质的结构不稳定,从而可以改变蛋白质的结构。
与其他蛋白质的相互作用(2,38,41)。努力了解蛋白质相互作用如何介导复杂的生物过程是UAB研究人员支持的NINDS研究目标的主要组成部分。
核心C将促进这些领域的进展。
我们建议维持一个蛋白质相互作用核心,该核心在原核和真核表达系统中提供蛋白质的表达,该表达系统适合于蛋白质的体外纯化和体内表达、用于体外和体内表达的载体设计和选择、蛋白质的生物化学和成像表征。
本发明涉及包括FRET和裂解荧光素酶/GFP的相互作用、酵母双杂交筛选系统和用于串联亲和纯化(TAP)和质谱的构建体的产生。核心实验室的目标是加速生物重要蛋白质相互作用的鉴定和表征,而无需
在NINDS支持的各个实验室建立这些方法。核心实验室人员将协助研究者选择适当的筛选系统,生成用于筛选试验的表达载体构建体,并在筛选程序中提供故障排除和技术协助。的
核心实验室还将促进试剂交换,更重要的是,扩大信息和试剂共享资源(www.neurosciencecore.uab.edu/coreclinks.htm),
实验室与其他NINDS支持UAB的研究人员分享蛋白表达系统和相互作用蛋白筛选系统的相关经验。最后,核心实验室将限制这些方法的冗余开发,并允许更有效地利用NINDS提供的资源来研究复杂生物系统中的蛋白质功能,这些系统是NINDS支持的UAB研究人员的研究重点。表1提供了蛋白质相互作用核心C)与NINDS支持的UAB研究人员相互作用的几个例子。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William Jarvis Britt其他文献
William Jarvis Britt的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William Jarvis Britt', 18)}}的其他基金
Tegument Envelope Protein Interactions in CMV Envelopment
CMV 包膜中的皮膜包膜蛋白相互作用
- 批准号:
10573700 - 财政年份:2022
- 资助金额:
$ 20.51万 - 项目类别:
CMV Vaccines: Reinfection and Antigenic Variation
CMV 疫苗:再感染和抗原变异
- 批准号:
10019411 - 财政年份:2019
- 资助金额:
$ 20.51万 - 项目类别:
CMV Vaccines: Reinfection and Antigenic Variation
CMV 疫苗:再感染和抗原变异
- 批准号:
10488568 - 财政年份:2019
- 资助金额:
$ 20.51万 - 项目类别:
CMV Vaccines: Reinfection and Antigenic Variation
CMV 疫苗:再感染和抗原变异
- 批准号:
10686167 - 财政年份:2019
- 资助金额:
$ 20.51万 - 项目类别:
CMV Vaccines: Reinfection and Antigenic Variation (Vision and auditory screening in infants born to women enrolled in ZIP)
CMV 疫苗:再感染和抗原变异(参加 ZIP 的妇女所生婴儿的视力和听觉筛查)
- 批准号:
9472616 - 财政年份:2017
- 资助金额:
$ 20.51万 - 项目类别:
Inflammation and Hearing Loss Following Congenital CMV Infection
先天性巨细胞病毒感染后的炎症和听力损失
- 批准号:
9759910 - 财政年份:2017
- 资助金额:
$ 20.51万 - 项目类别:
Inflammation and Hearing Loss Following Congenital CMV Infection
先天性巨细胞病毒感染后的炎症和听力损失
- 批准号:
10238050 - 财政年份:2017
- 资助金额:
$ 20.51万 - 项目类别:
HCMV miRNA Regulation of Secretion and Formation of the Viral Assembly Compartment
HCMV miRNA 对病毒装配室的分泌和形成的调节
- 批准号:
9883699 - 财政年份:2016
- 资助金额:
$ 20.51万 - 项目类别:
HCMV miRNA Regulation of Secretion and Formation of the Viral Assembly Compartment
HCMV miRNA 对病毒装配室的分泌和形成的调节
- 批准号:
9250666 - 财政年份:2016
- 资助金额:
$ 20.51万 - 项目类别:
Congenital CMV and CNS Infection Mechanisms of Protective Immunity
先天性巨细胞病毒和中枢神经系统感染的保护性免疫机制
- 批准号:
8450754 - 财政年份:2011
- 资助金额:
$ 20.51万 - 项目类别:
相似海外基金
Clinical application of boron-conjugated adenovirus vector for neutron capture therapy
硼缀合腺病毒载体中子捕获治疗的临床应用
- 批准号:
19K09482 - 财政年份:2019
- 资助金额:
$ 20.51万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Vascular-targeted gene therapy to block proliferation of smooth muscle cells using a novel adenovirus vector
使用新型腺病毒载体进行血管靶向基因治疗以阻止平滑肌细胞增殖
- 批准号:
2273599 - 财政年份:2019
- 资助金额:
$ 20.51万 - 项目类别:
Studentship
Gene therapy for diabetes mellitus based on the suppression of lipotoxicity using an improved adenovirus vector
使用改进的腺病毒载体抑制脂毒性的糖尿病基因治疗
- 批准号:
18K14964 - 财政年份:2018
- 资助金额:
$ 20.51万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mechanisms of induction of mucosal immunity by adenovirus vector vaccine
腺病毒载体疫苗诱导粘膜免疫的机制
- 批准号:
16K18873 - 财政年份:2016
- 资助金额:
$ 20.51万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Hemophilia B Gene Therapy via CRISPR/Cas9-Targeted Integration of the Factor IX Gene using Adenovirus Vector Delivery
使用腺病毒载体递送通过 CRISPR/Cas9 靶向整合因子 IX 基因进行 B 型血友病基因治疗
- 批准号:
9193681 - 财政年份:2016
- 资助金额:
$ 20.51万 - 项目类别:
Gene therapy for diabetes mellitus and gene function analysis using a novel adenovirus vector
使用新型腺病毒载体进行糖尿病基因治疗和基因功能分析
- 批准号:
15K18939 - 财政年份:2015
- 资助金额:
$ 20.51万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Innate immue response through glycolipids by adenovirus-vector
腺病毒载体通过糖脂产生先天免疫反应
- 批准号:
26450450 - 财政年份:2014
- 资助金额:
$ 20.51万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of a novel method for highly efficient gene targeting by adenovirus vector on human naive pluripotent stem cells
开发一种通过腺病毒载体高效基因靶向人类幼稚多能干细胞的新方法
- 批准号:
26893253 - 财政年份:2014
- 资助金额:
$ 20.51万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Development of targeting adenovirus vector as boron carrier for boron neutron capture therapy
开发靶向腺病毒载体作为硼中子捕获疗法的硼载体
- 批准号:
26462183 - 财政年份:2014
- 资助金额:
$ 20.51万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of adenovirus vector lacking VA RNA genes for efficient microRNA expression
开发缺乏 VA RNA 基因的腺病毒载体以实现有效的 microRNA 表达
- 批准号:
24701021 - 财政年份:2012
- 资助金额:
$ 20.51万 - 项目类别:
Grant-in-Aid for Young Scientists (B)














{{item.name}}会员




